Integrated Healthcare for Better Patient Outcomes

Apollo Medical Holdings, Inc.

Investor Presentation

Aug 2015

Safe Harbor Statement

This presentation may contain forward-looking statements, including information about management's view of

Apollo Medical Holdings, Inc. (“the Company”) future expectations, plans and prospects. In particular, when used

in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar

conditional expressions are intended to identify forward-looking statements. Any statements made in this

presentation other than those of historical fact, about an action, event or development, are forward-looking

statements. These statements involve known and unknown risks, uncertainties and other factors, which may

cause the results of the Company, its subsidiaries and concepts to be materially different than those expressed or

implied in such statements. Unknown or unpredictable factors also could have material adverse effects on the

Company’s future results. The forward-looking statements included in this presentation are made only as of the

date hereof. The Company cannot guarantee future results, levels of activity, performance or

achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally,

the Company undertakes no obligation to update these statements after the date of this release, except as

required by law, and also takes no obligation to update or correct information prepared by third parties that are

not paid for by Apollo Medical Holdings, Inc.

2

Summary

An integrated, physician driven, population healthcare management company

Medical Management, Care Coordination and Physician Care for 100,000+ people

Nearly 200% year-over-year revenue growth; majority organic and recurring

$33.0 Million FY 2015 vs. $11.2 Million in FY 2014; EBITDA positive in Fiscal Year and Q4 2015

Trailing twelve months revenue of nearly $40M (Market Cap less than 1X revenue at approx. $38M)

One of few small cap public companies in attractive healthcare services sector

Increasing flow of investment capital into sector, robust M&A valuations and IPOs

Recent IPOs of Evolent Health and acquisition of IPCM indicate market valuation

Fresenius Medical Care invested $12 Million in March 2014

Growth strategy to include geographic expansion and acquisitions of platform

3

Equity Overview

OTC: AMEH (NASDAQ Uplist Pending Approval)

Outstanding Shares: 4.9 Million

Recent Price: $8.00

52 week range: $4.50 - $10.00

Market Capitalization: $38M

Enterprise Value: $44M

Price / Sales: <1.0 X ttm

Fiscal Year ends March 31, 2015

4

ApolloMed Overview

Integrated physician healthcare services

Population Health Management

Management of complex, chronically ill patients

Technology and data driven analytics

Medical Management and Care Coordination

Management of Total Cost of Care for population

Direct Patient Care (augments population health mgt. and influences care)

Inpatient Care: Hospitalists, Critical Care Specialists, Physician Advisors

Outpatient Care: Primary Care Physicians, Specialists, Clinics, Home Health

5

Diversified Revenue

Revenue from Hospitals, Health Plans, Medical Groups and Government

Range of payments from Fee for Service (FFS) to Full Risk models

Maverick is capitated entity paid monthly from Health Plan Premiums

Scalable model with focus on growing integrated platform outside of California

ApolloMed has 50+ different payors

6

7

ApolloMed Model – Inpatient and Outpatient Care Driving Patient Outcomes

ApolloMed ACO (709 exclusively signed physicians & nearly 30,000 Medicare FFS patients)

– Population Management

– Care Coordination

Maverick Medical Group (IPA) (150+ PCP, 400+ specialists, & 10,000+ patients )

– Capitated entity

– Provider and full risk medical management

ApolloMed Hospital Physician Services (70+ hospitalists serving 28+ facilities)

– Hospitalist and Physician Advisory Services

– Post-acute services

ApolloMed Care Clinics

Primary Care

Cardiovascular / Specialty Care

Palliative Care

Home Health

Hospice

CLIN

ICA

L E

XP

ER

TIS

E

Industry Trends

Government and private sector trend from FFS/volume to outcome driven

Value based reimbursement, Bundled Payments, ACO, PTN

Irrespective of politics, better care and lower cost goals will continue

Transparency of information; by procedure, by physician, by hospital

New physician driven models forming and gaining traction

Physician and Patients are core of healthcare in emerging landscape

By 2016, 85% of Medicare payments will be tied to quality and value

By 2018, at least 50% of payments will be paid through “Alternative

payment models” , such as ACOs, PTNs, Bundled payments

Consumers are becoming more engaged in their own care

Exchanges, Rising Premiums, Social Media

8

Healthcare and Healthcare Delivery Market is Large and Growing

Seniors are increasing in number and living longer

76 Million baby boomers

3.6 Million new Seniors every year

US Healthcare market

$2.8 Trillion in 2012

Growing to nearly $4.8 Trillion by 2021

50+% US spend is on Hospital and Physician Care

(Bio and IT only about 20% total)

Healthcare is ~17% of US GDP heading to near 20%

of US GDP by 2021

All signs point to increased market size and need to

optimize healthcare costs into the next decade

9

10

Senior Market Growth is Significant

Apollo Differentiators

Ability to not only manage, but impact care when needed most

Expertise in providing high quality, cost efficient care

Expertise in managing complex, chronically ill patients

ApolloMed built on “emerging” trend of value based healthcare

Data analytics; past, current and predictive (i.e. goal of “real time”)

Population management and care coordination capabilities

Ability to take performance risk for total patient care profitably; most critical

attribute inn new value based US healthcare system

11

Some detailed examples of the “Secret Sauce” – Network Building

Network Providers (Maverick and ApolloMed ACO)

Potential for higher revenue from additional patients through Apollo network

Fixed rate PMPM and shared savings payment models (i.e. get paid for each patient)

Access to “full picture of patients” through data and technology

Assistance with coding and transition to value based care US Healthcare System

Alternative for physicians to remain independent; not employed by hospital or health plan

Staff Model Doctors

Increased compensation

Flexible scheduling (one week on/one week off)

No billing or credentialing headaches, Malpractice Insurance, Hospital Privileges

12

13

ApolloMed Hospitalist Impact

Significant Outperformance - Sample Hospitalization Utilization Metrics

3.3

6.8

6.1%

18.0%

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

ApolloMedMedicare LOS

Medical StaffMedicare LOS

ApolloMedMedi-Cal

Denial Rate

Medical StaffDenial Rate

Medicare Average LOS*

733

864

1,706

0

200

400

600

800

1,000

1,200

1,400

1,600

1,800

ApolloMed DaVita HCP Medicare FFS

Senior Inpatient Bed Days/1,000 Patients

*LOS=length of stay; Performance Year 1= July 2012 to December 2013

687

543

0

500

1000

Benchmark Performance Year 1*

ApolloMed ACO Hospitalization Rate per 1,000

14

Significant Outperformance - Sample Hospitalization Utilization Metrics

189

258

302

0

50

100

150

200

250

300

350

Maverick IPA California National

Senior Admits/1,000

230

195

170

180

190

200

210

220

230

240

Benchmark Performance Year 1

ApolloMed ACO 30-Day All-Cause Readmission per 1,000

Discharges

78.4%

86.3%

74%

76%

78%

80%

82%

84%

86%

88%

Maverick IPA National

Senior Medical Loss Ratio (MLR)

Network Building is growing and starting to impact financials …

15

PY1 PY2

48

175

400

0

100

200

300

400

500

Number of Maverick Doctors

130

709

0

100

200

300

400

500

600

700

800

Number of ACO Doctors

2012 2013 2014

PY1 PY2

0

5,000

10,000

0

2,000

4,000

6,000

8,000

10,000

12,000

Number of Maverick Patients

2012 2013 2014

10,200

30,000

0

10,000

20,000

30,000

40,000

Number of ACO Patients

16

… as revenue has jumped nearly 200% Y/Y and quarterly growth achieved

0

5

10

15

20

25

30

35

FY2013 FY2014 FY2015

Apollo Annual Revenue

Apollo Annual Revenue

Note: Fiscal year 2015 is from April 1, 2014 to March 31st, 2015

$33 Million

Income Statement and Balance Sheet Summary

FY 2015 revenue of $33.0M vs. $11.2M Y/Y (195% gain)

Nearly 70% of this growth is organic and recurring

Emphasis on Maverick IPA, ACO and acquisition growth

FY 2015 Net Loss of ($.7M) vs. ($4.4M) in FY 2014

Loss improvement while making infrastructure investments

FY 2015 EBITDA of $467K and Gross Profit Margin of 33%

Operating businesses generating cash

Q4 2015 revenue increase of $9.6M from $3.2M; 200% gain

Total Assets of $15.0M and Cash/Equivalents of $5.0M

17

Business Strategy

Scale current businesses in California

Establish and grow networks outside of California leveraging

clinical know how and technology

Emphasize Population Management Growth

Focus on strategic acquisitions in attractive geographies

Continue to scale infrastructure including centralized data

analytics and “real-time” technology advances

Continue to assume and manage medical and financial risk

18

More than 20 years in managed care industry

Previously COO of Prospect Medical Group, managing over 250,000

patients in 13 IPAs. Former Regional Vice President of Cigna Health Plan

Co-founder

Medical degree from the University of California, Irvine

Diplomate of the American Board of Internal Medicine

Early partner of HealthCare Partners (acquired by DaVita).

Visionary in the fields of Palliative Care and Hospital-at-Home Care

30 year veteran in the field

Appointed CFO in May 2014. Director since 2012.

Former CEO of USC University Hospital and USC/Norris Cancer Center;

former CFO and Vice Chancellor of UCLA Medical Center; former CFO of

Beth Israel Deaconess Medical Center and Tufts University Medical Center.

Co-founder

Medical degree from the Georgetown University School of Medicine and

completed Residency in Internal Medicine at USC

Our Leadership

Warren Hosseinion, M.D.

CEO & Director

Mitchell Creem

CFO & Director

Liviu Chindris, M.D

President of Apollo Palliative Services

Adrian Vazquez, M.D.

Chief Medical Officer

Mark Marten

President, Maverick Medical Group

19

CEO of SCAN, 10th largest MA plan in the U.S.

Expertise in Government relations, Knox Kneene and Healthcare IT

CEO of Appzure, Inc.

Founder and CEO of Accelerated Networks, which he took public on the

NASDAQ in 2000.

37 years in private and public healthcare sectors

CEO of USC University Hospital and USC/Norris Cancer Hospital

Former Senior Vice President of Operations for Tenet

Board of Directors

Strategy, Capital, M&A, and Corporate Development for ApolloMed (FT role)

Served as CEO, Corp Dev/M&A, Consultant roles with S&P 500 (Prudential

Healthcare, Fluor, Fed Ex ) and growth healthcare and technology companies

Gary Augusta

Executive Chairman

Ted Schreck

Director

Suresh Nihalani

Director

David Schmidt

Director

Warren Hosseinion, M.D.

CEO & Director

Founder and managing partner of SEC Law Firm in Los Angeles.

Over 25 years of experience in public and private securities offerings, IPOs,

SEC reporting, corporate governance and M&A. Has given testimony to the

SEC’s Advisory Committee of the American Bar Association. J.D. from NYU.

Lance Kimmel

Director

Mitchell Creem

CFO & Director

20

Valuations are robust and accelerating for value based, risk taking models

Evolent (NYSE: EVH) – IPO June 5th

Population Management and Value Based Care Offerings

$1+B valuation on $100M revenues with operating losses (S1 data)

OSCAR

Valued at $1.5 Billion with 40,000 risk lives and $200M revenue

NY/NJ focus with Goldman Sachs investment

Humana and Health Net Acquisitions

Large Equity gains and potential for more M&A (Pop Mgt. and Risk rationale)

Hospitalist/ER and Integrated Care Companies

Davita/HCP merger and Team Health (TMH)/IPC (IPCM) merger as examples

Valued around 1.5X-2.5X ttm revenues and 10X to 20+X EBITDA multiples

21

AMEH Shareholder Overview

OTC: AMEH (NASDAQ Uplist Pending Approval)

Outstanding Shares: 4.9 Million

Recent Price: $8.00

52 week range: $4.50 - $10.00

Market Capitalization: $38M

Enterprise Value: $44M

Price / Sales: <1.0 X ttm

Fiscal Year ends March 31, 2015

22